Takeda Pharmaceutical Co Ltd ADR
Price & Volume
Stats
See moreOpen | $15.06 |
Previous Close | $15.19 |
Day Range | $14.89-$15.19 |
52W Range | $12.28-$15.37 |
Market Cap | $47.9B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $4.5T |
Revenue Growth (YoY) | 3% |
Gross Profit (12 Mos) | $2.9T |
Diluted EPS | $0.43 |
News
See moreYahoo Finance • 2 months ago
Is Takeda Pharmaceutical Company Limited (TAK) the Best Japanese Stock to Buy in 2025?
Yahoo Finance • 2 months ago
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Yahoo Finance • 2 months ago
Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age
Yahoo Finance • 2 months ago
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
About
CEO | Mr. Christophe Weber |
CFO | Mr. Milano Furuta |
Address | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 49,281 |
